Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Asthma

- Asthma
- Completed

Study Title: A Dose-ranging Study to Evaluate Albuterol and Hydrofluoroalkane in Subjects Ages 12 and Older With Persistent Asthma

Teva Identifier: ABS-AS-201

ClinicalTrials.gov Identifier: NCT01058863

Study Status: Completed

Trial Condition(s): Asthma

Interventions: Drug: Albuterol Spiromaxֲ® | Drug: ProAirֲ® HFA | Other: Placebo Inhaler

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age group: Child, Adult, Older Adult

Age Range: 12 Years and older

Trial Duration: 02/01/2010 - 06/01/2010

Phase: Phase 2

Study Type

Interventional